Cargando…
Rivaroxaban in heart failure patients with left ventricular thrombus: A retrospective study
Background: The role of rivaroxaban in patients with heart failure (HF) combined with left ventricular (LV) thrombus remains unknown in current guideline-directed anticoagulant therapy. The aim of this study was to investigate the impact on clinical outcomes of rivaroxaban compared to vitamin K anta...
Autores principales: | Zhang, Qian, Zhang, Zhongfan, Zheng, Haikuo, Qu, Ming, Li, Shouping, Yang, Ping, Si, Daoyuan, Zhang, Wenqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585209/ https://www.ncbi.nlm.nih.gov/pubmed/36278225 http://dx.doi.org/10.3389/fphar.2022.1008031 |
Ejemplares similares
-
Value of the platelet-to-lymphocyte ratio in the prediction of left ventricular thrombus in anterior ST-elevation myocardial infarction with left ventricular dysfunction
por: Zhang, Qian, et al.
Publicado: (2020) -
Prognosis and New Predictors of Early Left-Ventricular Thrombus Following ST-Elevation Myocardial Infarction
por: Zhang, Qian, et al.
Publicado: (2021) -
Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation
por: Zhang, Qian, et al.
Publicado: (2023) -
Rivaroxaban, a direct inhibitor of coagulation factor Xa, attenuates adverse cardiac remodeling in rats by regulating the PAR-2 and TGF-β1 signaling pathways
por: Zhang, Qian, et al.
Publicado: (2023) -
Loeffler endocarditis with intracardiac thrombus: case report and literature review
por: Zhang, Qian, et al.
Publicado: (2021)